Effects of Therapeutic Mobile Game on Anxiety
Trial Summary
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What is the purpose of this trial?
This trial tests a mobile app called ABM-01 to help adults aged 22-65 with Social Anxiety Disorder. Participants use the app regularly for a period to manage and reduce their social anxiety symptoms.
Research Team
Tracy A Dennis-Tiwary, PhD
Principal Investigator
City University of New York, School of Public Health
Eligibility Criteria
Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Session
Participants complete baseline assessments before starting treatment
30-Day Treatment Phase
Participants use the digital therapeutic ABM-01 and complete assessments remotely
Post-Treatment Session
Participants complete assessments after the treatment phase
6-Month Follow-Up Session
Participants are monitored for safety and effectiveness 6 months after treatment
12-Month Follow-Up Session
Participants are monitored for safety and effectiveness 12 months after treatment
Treatment Details
Interventions
- ABM-01
- Digital Control
Find a Clinic Near You
Who Is Running the Clinical Trial?
Hunter College of City University of New York
Lead Sponsor
Wise Therapeutics Inc.
Collaborator
Arcade Therapeutics Inc.
Collaborator